At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Head of The Lab – OverviewThe Lab is Roche’s enterprise capability that delivers content services and digital engagement across the organization. It combines execution, AI, content, technology, operations and delivery to provide high-quality, scalable customer engagement.ResponsibilitiesDefine the 5‑year vision,
Roche Holding AG in Basel is seeking a strategic leader to head The Lab, Roche’s enterprise capability for content services and digital engagement. The role focuses on translating strategy into scalable execution across global affiliates.As Head of The
F. Hoffmann-La Roche AG invites a transformative leader to define the 5-year vision and operating model for The Lab, Roche’s enterprise capability for content services and digital engagement.You will guide the evolution into a modern, AI-enabled organization, overseeing
This role is hybrid, with an expectation of working an average of 2 days per week from an HPE office. Company Overview Hewlett Packard Enterprise is a global edge‑to‑cloud company advancing the way people live and
About TetraScience TetraScience is the Scientific Data and AI Company building Tetra OS, the operating system for scientific intelligence. We help the world’s leading life sciences firms turn fragmented scientific data into AI-native assets and scientific
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Your responsibilities : Fair marketing & brand experience Serve as the global owner of fair marketing and experiential initiatives, shaping frameworks, prioritisation, final sign-off for integrated campaigns across all Art Basel shows with clear cultural brand
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Location: Basel Switzerland, 3 days/week in office About The Role The Global Head of Technology & Architecture in Biomedical Research (BR) will spearhead our information technology strategy in drug discovery and early clinical development, ensuring our
CEO / Chief Commercial Officer (Equity + Base) Drive the launch and scale-up of Aeonix, a next-generation preventative health platform in Switzerland, combining advanced diagnostics, AI-driven insights, and integrated EHR capabilities. Key Responsibilities Lead overall commercial
Chez Roche, vous pouvez être vous-même et être apprécié pour les qualités uniques que vous apportez. Notre culture encourage lexpression personnelle, le dialogue ouvert et les connexions authentiques, où vous êtes valorisé, accepté et respecté pour
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
1 out of 10 people are diagnosed with an autoimmune or autoinflammatory disease. This is why the Autoimmunity, Transplantation & Inflammation (ATI) Disease Area group at the Novartis Institutes for Biomedical Research (NIBR) is investing in